Navigation Links
Lexicon's Drug Candidate LX1032 for Carcinoid Syndrome Receives Orphan Drug Designation From EMEA
Date:7/21/2009

THE WOODLANDS, Texas, July 21 /PRNewswire-FirstCall/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, announced today that it has received orphan drug designation from the Committee for Orphan Medical Products (COMP) of the European Medicines Agency (EMEA) for LX1032, the company's oral drug candidate for managing gastrointestinal symptoms associated with carcinoid syndrome. LX1032 is designed to reduce serotonin production in patients with metastatic carcinoid tumors. Elevated levels of serotonin contribute to the gastrointestinal and possibly other symptoms experienced by these patients.

The EMEA is a regulatory agency in the European Union (EU) primarily responsible for the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use. The goal of EMEA's orphan drug program is to promote the development of drugs intended for the prevention or treatment of life-threatening or chronically debilitating conditions that affect no more than five in 10,000 people in the EU. Incentives for developing new drugs under orphan drug designation in the EU include 10 years of marketing exclusivity, regulatory assistance, reduced regulatory fees associated with applying for marketing approval, and assistance with clinical trial design. LX1032 is the first drug candidate for which Lexicon has obtained orphan drug status.

"Gaining orphan
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease; Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver Disease and Metabolic Syndrome
2. Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimers Disease
3. Vantia Therapeutics Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia
4. CeNeRx BioPharma Obtains Rights to Novel Drug Candidate for Prevention and Treatment of Neurodegeneration Disorders
5. Proteolix, Inc. Drug Candidate, PR-957, Prevents Disease Progression in Rheumatoid Arthritis Models by Selective Inhibition of the Immunoproteasome
6. Lilly Advances Second Alzheimers Disease Treatment Candidate Into Late-Stage Testing by Launching Two Global Trials
7. Arcion Therapeutics Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy
8. Potentia Pharmaceuticals POT-4 Drug Candidate for Age-Related Macular Degeneration Successfully Completes Phase I Clinical Trial - Prepares for Phase II
9. First Candidate from Esperances Targeted Anti-cancer Platform, EP-100, Establishes Preclinical Proof of Concept
10. Optimer Pharmaceuticals Receives Production Patent for Lead Product Candidate Fidaxomicin
11. AACR Data Highlights InNexus Preclinical Antibody Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... TWINSBURG, Ohio , Aug. 31, 2015 /PRNewswire/ ... and applications, has acquired MACTek Corporation, a leading ... part of Pepperl+Fuchs, strategy to further extend its ... the WirelessHART market.    "We are ... to our existing portfolio," said Jim Bolin ...
(Date:8/31/2015)... , Aug. 31, 2015  Daktari Diagnostics today announced a ... United States and Canada , ... The deal, worth up to $8.5 million over the next ... clinical validation and regulatory approval of Daktari,s HCV test. ... point-of-care instrument that can detect low levels of virus directly ...
(Date:8/31/2015)... , Aug. 31, 2015  On August 5, 2015, ... Oregon denied motions to dismiss securities ... GALE ) and certain of its directors. The class ... "pump and dump" scheme to artificially inflate Galena,s stock ... the stock price was inflated, sold massive amounts of ...
Breaking Medicine Technology:Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 2Daktari Enters Collaboration Agreement with Merck to Develop Test for Hepatitis C Virus 3Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty 2
... Mich., Oct. 19 Stryker Corporation (NYSE: SYK ... 2010 as follows: Third Quarter Highlights ... currency basis (6.9% as reported) to $1,768 million Orthopaedic ... as reported) MedSurg Equipment sales increased 16.3% on ...
... SCOTTSDALE, Ariz., Oct. 19 Matrixx Initiatives, Inc. (Nasdaq: ... financial results for the fiscal 2011 second quarter and six ... market closes on Monday, October 25, 2010. An earnings conference ... 26, 2010 at 11:00 AM ET. To access ...
Cached Medicine Technology:Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 2Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 3Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 4Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 5Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 6Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 7Stryker Reports 7% Sales Growth, 14% Adjusted Net Earnings Growth for Quarter Ended September 30, 2010 8Matrixx Initiatives, Inc. Sets Time for Discussion of Fiscal 2011 Second Quarter Financial Results 2
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... Connectivity Kit is now available. With the Connectivity Kit, EasySampler data ... automated jacketed lab reactor control experiment, on a touchscreen platform. , EasySampler fully ...
(Date:9/1/2015)... ... 2015 , ... Mercy Health (formerly Catholic Health Partners) – a Catholic healthcare ... Health: Helping You Be Well videos to prostate cancer awareness. Prostate cancer is the ... concise video on Mercy Health’s YouTube channel, Mercy Health experts address issues, such as:, ...
(Date:9/1/2015)... ... September 01, 2015 , ... Ogawa’s new massage chairs tout ... more effective and humanlike than ever before. With the goal of bringing wellness to ... the Ogawa Active SuperTrac. , As in its name, the Ogawa Refresh ...
(Date:9/1/2015)... ... September 01, 2015 , ... USA Medical Card, ... this week to coincide with back-to-school and the start of “sick season” for ... CDC, elementary school children are sick an average of 8 to 12 times ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... VitaSkin™ collection of products, the VitaSkin™ Exfoliating Peels. This revolutionary collection of natural ... Firm, Bright, Calm, and Clear. , Formulated with alpha hydroxy acids and ...
Breaking Medicine News(10 mins):Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 2Health News:New Technology Allows Unattended Sampling and Synthesis of Chemical Reactions 3Health News:New Mercy Health Video Explains Most-Common Cancer Found in Men 2Health News:Ogawa World USA Releases New Massage Chairs to the US 2Health News:Ogawa World USA Releases New Massage Chairs to the US 3Health News:USA Medical Card Launches New FAQ Video During Back-to-School 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 3
... Solution Offers Better Patient Care and Reduced Costs ... Effectively Managing IT Service Delivery with Significant ROI, ... CPWR ) today launched a new initiative to ... effectively navigate the dynamically,changing healthcare technology environment. By ...
... Is Awarding Over One Million Dollars to Help People ... Lose Weight and Get in Better Shape, ... a $50,000 Grand Prize winner in,its Million Dollar Body Game(TM), an ... spur people to lose weight and get,in shape. Jacob Anderson from ...
... Body(TM) Is Awarding Over One Million Dollars to Help People ... Lose Weight and Get in Better ... announced a $50,000 Grand Prize winner in,its Million Dollar Body Game(TM), ... to spur people to lose weight and get,in shape., Phyllis ...
... Over One Million Dollars to Help People ... Lose Weight and Get in Better Shape, ANAHEIM, ... Grand Prize winner in,its Million Dollar Body Game(TM), an ongoing incentive ... to lose weight and get,in shape. Scott Shoup from Columbus, Ohio ...
... Homicide is the second leading cause of death for ... youth. In an important special supplement to the March ... 14 contributions from a diverse group of researchers and ... need to reduce and prevent youth violence and explore ...
... Arthroscopy kept function at 93% of pre-injury levels among ... (HealthDay News) -- Arthroscopic surgery for first-time shoulder dislocation ... a U.S. study. , "In young, active patients, there ... would dislocate their shoulder again when conservative approaches like ...
Cached Medicine News:Health News:Compuware Launches Strategic IT Service Management Initiative for Healthcare Industry 2Health News:Compuware Launches Strategic IT Service Management Initiative for Healthcare Industry 3Health News:Virginia Beach Man Loses 17 Pounds, on Top of a Previous 100 Pound Loss, and Wins Major $50,000 Prize 2Health News:Virginia Beach Man Loses 17 Pounds, on Top of a Previous 100 Pound Loss, and Wins Major $50,000 Prize 3Health News:Knoxville, TN Woman Wins $50,000 for Losing 77 Pounds 2Health News:Knoxville, TN Woman Wins $50,000 for Losing 77 Pounds 3Health News:Columbus, OH Man Wins $50,000 for Losing 71 Pounds 2Health News:Columbus, OH Man Wins $50,000 for Losing 71 Pounds 3Health News:Experts call for community mobilization to curb youth violence 2Health News:Experts call for community mobilization to curb youth violence 3Health News:Experts call for community mobilization to curb youth violence 4Health News:First-Time Shoulder Dislocations Helped by Surgery 2
... Packard-brand FlexDrop is an innovative reagent ... development. Designed to fulfill the need ... reagents, solvents and more, FlexDrop provides ... time consuming and tedious task of ...
Multidrop Micro high speed 1 l bulk reagent dispenser rapidly, precisely and accurately dispenses microvolumes of 1-50 l into 384- and 96-well microplates....
... high throughput dispensing. Multidrop 384 offers ... throughput, particularly for screening applications. The ... designed for high-throughput screening and microvolume ... This new-generation dispenser offers outstanding flexibility. ...
RIA kit for the determination of autoantibodies to the muscle-specific receptor tyrosine kinase....
Medicine Products: